Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. |
Oscar Health Reports Its First Profit As Insurer’s Enrollment Soars Oscar Health reported a $177 million first quarter profit — its first since the company was founded — as its Obamacare enrollment soared more than 40%. |
Píše se o |